Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial

BACKGROUND: Based on non-clinical data, it is expected that azilsartan, an angiotensin II receptor blocker, will help improve insulin resistance in addition to its hypotensive action. The present study is aimed to explore the effect of azilsartan compared to telmisartan on insulin sensitivity in hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Naruse, Mitsuhide, Koike, Yasuhiro, Kamei, Nozomu, Sakamoto, Ryuichi, Yambe, Yuko, Arimitsu, Michinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447197/
https://www.ncbi.nlm.nih.gov/pubmed/30943275
http://dx.doi.org/10.1371/journal.pone.0214727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447197/
https://www.ncbi.nlm.nih.gov/pubmed/30943275
http://dx.doi.org/10.1371/journal.pone.0214727

Ejemplares similares